邓世忠 冯健 廖晓星 胡春林 程伟雄 张凤英


【摘要】 目的:探討应用甲泼尼龙琥珀酸钠联合无创正压通气(Non-invasive positive pressure ventilation,NPPV)治疗呼吸衰竭的临床研究。方法:选取本院2014年1月-2017年2月收治的急性呼吸衰竭患者98例,按照随机数字表法分为观察组与对照组,每组49例。两组均于入院后进行常规治疗,观察组在常规治疗基础上给予甲泼尼龙琥珀酸钠联合NPPV治疗。比较两组治疗前和治疗24 h收缩压、舒张压、心率、血pH、PaO2、PaCO2、呼吸困难改善时间和平均住院时间。结果:治疗24 h,两组收缩压和舒张压比较,差异均无统计学意义(P>0.05),观察组心率低于对照组(P<0.05);治疗24 h,两组血pH、PaO2水平均增加,而PaCO2水平降低(P<0.05);治疗24 h,观察组血pH、PaO2水平均高于对照组,而PaCO2水平低于对照组(P<0.05);观察组呼吸困难改善时间和平均住院时间均优于对照组(P<0.05)。结论:甲泼尼龙琥珀酸钠联合NPPV治疗呼吸衰竭患者效果显著,具有重要研究意义。
【关键词】 甲泼尼龙琥珀酸钠; 无创正压通气; 呼吸衰竭
Clinical Study of Methylprednisolone Sodium Succinate Combined with Noninvasive Positive Pressure Ventilation in the Treatment of Respiratory Failure/DENG Shi-zhong,FENG Jian,LIAO Xiao-xing,et al.//Medical Innovation of China,2017,14(26):105-108
【Abstract】 Objective:To explore the application of Methylprednisolone combined with non-invasive positive pressure ventilation(NPPV) in the treatment of respiratory failure.Method:A total of 98 cases of acute respiratory failure in our hospital from January 2014 to February 2017 were selected and divided into the observation group and the control group according to the random number table method,49 cases in each group.Two groups admitted to hospital were given routine treatment,the observation group was given Methylprednisolone Sodium Succinate combined with NPPV treatment on the basis of routine treatment.Systolic blood pressure,diastolic blood pressure,heart rate,blood pH,PaO2,PaCO2,dyspnea improvement time and average length of stay of two groups before treatment and after treatment of 24 h were compared.Result:After treatment of 24 h,there were no statistical significance in systolic and diastolic blood pressure of two groups(P>0.05),and heart rate of the observation group was lower than that of the control group(P<0.05).Blood pH,PaO2 levels of two groups increased,and PaCO2 decreased(P<0.05).Blood pH,PaO2 levels of the observation group were higher than those of the control group,and PaCO2 level of the observation group was lower than that of the control group(P<0.05).Dyspnea improved time and hospitalization time of the observation group were better than those of the control group(P<0.05).Conclusion:Methylprednisolone Sodium Succinate combined with NPPV is effective in the treatment of respiratory failure,it has the important research significance.
【Key words】 Methylprednisolone Sodium Succinate; Noninvasive positive pressure ventilation; Respiratory failure
First-authors address:Gaozhou City Peoples Hospital,Gaozhou 525200,Chinaendprint
doi:10.3969/j.issn.1674-4985.2017.26.027
急性呼吸衰竭是常见的一种呼吸内科疾病,可由慢性疾病急性发作所致,也可由急性创所、应激所致[1]。如慢性阻塞性肺疾病急性发作、肺挫伤、急性肺水肿、Ⅰ型呼吸衰竭等均可致使呼吸衰竭发生[2]。由于急性呼吸衰竭具有病情重、变化快等特点,临床上若不采取及时有效的处理措施,最终可能使患者致残甚至危及生命[3-4]。目前,临床上对急性呼吸衰竭采取及时有效的治疗方法尤为重要。故而,本研究旨在探讨甲泼尼龙琥珀酸钠联合无创正压通气(Non-invasive positive pressure ventilation,NPPV)治疗急性呼吸衰竭的临床研究,现报道如下。
1 资料与方法
1.1 一般资料 选择本院2014年1月-2017年2月收治的急性呼吸衰竭患者98例。按照随机数字表法将其分为观察组和对照组,每组49例。观察组男29例,女20例;年龄18~80岁,平均(53.24±5.46)岁。对照组男30例,女19例;年龄20~79岁,平均(54.12±6.14)岁。两组患者一般资料比较差异无统计学意义(P>0.05)。……p>